GR 103691

CAS No. 162408-66-4

GR 103691( —— )

Catalog No. M23720 CAS No. 162408-66-4

GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 55 In Stock
10MG 91 In Stock
25MG 186 In Stock
50MG 295 In Stock
100MG 478 In Stock
500MG 1062 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GR 103691
  • Note
    Research use only, not for human use.
  • Brief Description
    GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).?
  • Description
    GR 103691 is a potent, selective dopamine D3 receptor antagonist (Ki: 0.4 nM).?It shows more than 100-fold selectivity for human dopamine human (h)D3 over hD4 and hD1 sites.
  • In Vitro
    GR 103691 shows marked affinity for serotonin1A (5-HT1A) receptors (Ki of 5.8 nM) and α-1 adrenoceptors (Ki of 12.6 nM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    162408-66-4
  • Formula Weight
    485.62
  • Molecular Formula
    C30H35N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(C1=CC=C(C2=CC=C(C(C)=O)C=C2)C=C1)NCCCCN3CCN(C4=CC=CC=C4OC)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Audinot V, et al. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther. 1998 Oct;287(1):187-97.
molnova catalog
related products
  • Clebopride malate

    Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.

  • Fluphenazine decanoa...

    Fluphenazine decanoate is dopamine D2 receptor blockeand is a long-acting phenothiazine neuroleptic that used to treat schizophrenia.

  • NEO 376

    NEO 376 is a selective 5-HT1 receptor, GABA receptor and dopamine receptor modulator, showing anti-psychotic actively.